Advertisement

Topics

Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs

07:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Cycle Pharmaceuticals (“Cycle”) is pleased to announce the launch of a new program in the US to offer patients with hereditary tyrosinemia type 1 (HT-1) the opportunity to experience NITYR (nitisinone) tablets for free for ...

Other Sources for this Article

Cycle Pharmaceuticals
Paula Bekinschtein
Global Marketing Manager
Tel: +44 1223 803 636 (GMT)
Email: paula.bekinschtein@cyclepharma.com
Company’s website: www.cyclepharma.com

NEXT ARTICLE

More From BioPortfolio on "Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...